Texting to save lives: can a phone app get more black men screened for colon cancer?
NCT ID NCT06052202
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a smartphone-based program designed to help African American men get screened for colorectal cancer. 128 men who were not up-to-date on screening received either the new program (text messages with videos and quizzes) or standard educational texts. After 6 months, researchers checked medical records to see who got screened. The goal is to see if the interactive program works better than regular information at increasing screening rates.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- smartphone-based text messaging program with videos and web assessments
- What this could lead to
- If it works, this program could become a simple, scalable way to increase colorectal cancer screening among African American men, helping reduce health disparities.
- What could go wrong
- This is a completed trial with 128 participants, so results are preliminary. The program may not work as well in other groups or settings, and screening rates depend on many factors beyond the app.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
128 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 75 years
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * African American/Black * not compliant with current United States Preventive Services Taskforce colorectal cancer screening recommendations * owns a mobile phone capable of text messaging and accessing webpages * able to speak/understand English Exclusion Criteria: * personal history of colorectal cancer
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ISA Associates, Inc.
Alexandria, Virginia, 22314, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to why some cancer treatments work better
- Burning the edges: a new way to stop colon polyps from coming back
- Missed Follow-Up colonoscopies: do they raise the risk of advanced growths?
- A 2.2 mm scope could spot cancerous tissue in minutes, not days
- The gatekeepers of tumors: scientists probe how blood vessels let immune cells in
- New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers